Pancreatic Cancer Research

ResearcherJiangsu UniversityActive in the last 2 years

Hsiang‐i Tsai

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4233-1428; OpenAlex author ID A5069138081. Sources: OpenAlex.

Their work

Papers
6 (first author 0, last author 3)
Trials
0
Grants
0
Labs led
1
Collaborators
12
Papers, trials and grants by year

2023: 1 paper · 2024: 2 papers · 2025: none · 2026: 3 papers

Papers 6

  1. T‑Cell Immunoreceptor with Ig and Immunoreceptor Tyrosine-Based Inhibitory Motif Domains/Cluster of Differentiation 40 Cellular Nanovesicles Carrying Oxaliplat… Last author DOI 10.1021/acsptsci.6c00065↗
  2. Engineered Cell Membrane-Coated Nanoparticles: A New Strategy for Pancreatic Cancer Therapy. Co-author DOI 10.1021/acsptsci.6c00148↗
  3. ATP2B4 driven chromatin compaction exacerbates pancreatic cancer radiotherapy resistance. Co-author DOI 10.1038/s41420-026-03142-7↗
  4. Cancer-associated fibroblasts in pancreatic ductal adenocarcinoma therapy: Challenges and opportunities. Co-author DOI 10.1016/j.canlet.2024.216859↗
  5. Overcoming the limitations of immunotherapy in pancreatic ductal adenocarcinoma: Combining radiotherapy and metabolic targeting therapy. Last author DOI 10.7150/jca.92502↗
  6. KRAS mutation: The booster of pancreatic ductal adenocarcinoma transformation and progression. Last author DOI 10.3389/fcell.2023.1147676↗

Closest collaborators

The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zining Zhang · 3 shared papers, 2023–2026 · strength 0.85
  2. Wenlong Chen · 1 shared paper, 2026 · strength 0.30
  3. Ke Zhou · 1 shared paper, 2026 · strength 0.29
  4. Guoquan Feng · 1 shared paper, 2026 · strength 0.29
  5. Qin Qin · 1 shared paper, 2024 · strength 0.28
  6. Han Zhang · 1 shared paper, 2024 · strength 0.28
  7. Wenjin Xu · 1 shared paper, 2024 · strength 0.28
  8. Haitao Zhu · 1 shared paper, 2024 · strength 0.28
  9. Haitao Zhu · 1 shared paper, 2026 · strength 0.28
  10. Y F Luo · 1 shared paper, 2026 · strength 0.28
  11. Yuehua Chen · 1 shared paper, 2026 · strength 0.28
  12. Xiang Liao · 1 shared paper, 2023 · strength 0.26

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.